Showing results (451-460 of 564) with videos related to
Sort By:
Pageof 57
Oral Oncology|May 5, 2015
Comparison of every 3 week cisplatin or weekly cetuximab with concurrent radiotherapy for locally advanced head and neck cancerTobin J Strom, Andy M Trotti, Julie Kish, et al.Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|August 12, 2018
A multicenter, randomized, single-blind trial comparing the efficacy of viable cryopreserved placental membrane to human fibroblast-derived dermal substitute for the treatment of chronic diabetic foot ulcersCharles E Ananian, Yadwinder S Dhillon, Carl C Van Gils, et al.Journal of Geriatric Oncology|October 11, 2016
Increased acute mortality with chemoradiotherapy for locally advanced head and neck cancer in patients ≥70yearsTobin J Strom, Arash O Naghavi, Andy M Trotti, et al.Antimicrobial Agents and Chemotherapy|November 15, 2007
The mechanism of action of beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine involves a second metabolic pathway leading to beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymeraseEisuke Murakami, Congrong Niu, Haiying Bao, et al.Journal of Virology|April 13, 2012
Structure of hepatitis C virus polymerase in complex with primer-template RNARalph T Mosley, Thomas E Edwards, Eisuke Murakami, et al.Proceedings of the National Academy of Sciences of the United States of America|August 15, 1993
In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 proteaseM J Otto, S Garber, D L Winslow, et al.Head & Neck|April 22, 2016
Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high-risk salivary gland carcinomasMatthew J Mifsud, Tawee Tanvetyanon, Judith C Mccaffrey, et al.Oncology Reports|April 18, 2000
A multivariate analysis for predicting cisplatin-induced delayed emesisX Pivot, N Marghali, M C Etienne, et al.Die Rehabilitation|December 17, 2011
[Psychosocial predictors of utilization of medical rehabilitation services among prostate cancer patients]C Lehmann, V Beierlein, C Hagen-Aukamp, et al.Pharmacotherapy|December 17, 1997
Cisplatin nephrotoxicity: a multivariate analysis of potential predisposing factorsJ L Lagrange, B Médecin, M C Etienne, et al.Pageof 57